The low rate and apparent reversibility of class III or IV CHF that was observed when trastuzumab was combined with paclitaxel supported the comparison of AC followed by paclitaxel trastuzumab [Only registered and activated users can see links. Click Here To Register...] Finally, during the winter height of the COVID 19 pandemic, it was Alison s turn to ring the bell signifying the end of treatment
